The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech

Phase I study of AZD3759, a CNS penetrable EGFR inhibitor, for the treatment of non-small-cell lung cancer (NSCLC) with brain metastasis (BM) and leptomeningeal metastasis (LM).
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
Research Funding - AstraZeneca (Inst)
 
Dong-Wan Kim
No Relationships to Disclose
 
Tae Min Kim
No Relationships to Disclose
 
Chia-Chi Lin
No Relationships to Disclose
 
Jayantha Ratnayake
Employment - AstraZeneca
 
David J Carlie
Employment - AstraZeneca
 
Xiaolu Yin
Employment - AstraZeneca
 
Zhenfan Yang
Employment - AstraZeneca
 
Haiyi Jiang
Employment - AstraZeneca
 
James Chih-Hsin Yang
No Relationships to Disclose